Altis Biosystems

Durham, NC · Founded 2015 · Privately Held (backing)

Developer of a stem cell technology designed to recreate the human intestinal epithelium and colonic epithelium for compound screening and microbiome research. Altis Biosystems is based in Durham, NC and was founded in 2015. It was valued at $20 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $8.8 million across 3 recorded rounds; the latest was a $2.1 million seed round in Mar 2025.

PMV mark · valuation
$20.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$8.8M
Last round
Seed Round
Mar 2025

Who backs Altis Biosystems?

22 investors
InvestorType
National Institutes of HealthOther
Alexandria Venture InvestmentsOther
Triangle Tweener FundVenture capital
Hatteras Venture PartnersVenture capital
NC IdeaOther
2ndFFamily office
Gulf South Angels—
Atlanta Technology AngelsAngel
University of Michigan EndowmentOther
RTP Capital AssociatesOther
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Altis Biosystems investors

22 investors are on record for Altis Biosystems, including National Institutes of Health, Alexandria Venture Investments, Triangle Tweener Fund and Hatteras Venture Partners. The seed round in Mar 2025 drew 9 investors.

Free account
More of Altis Biosystems with a free account
  • ·The complete investor list: 22 names
  • ·Watch Altis Biosystems: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like Altis Biosystems. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View